Absynth Biologics Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Request demo

Absynth Biologics Ltd. - overview

About

Founded in 2007, Absynth Biologics is based in Sheffield, UK and operates as a developer of vaccines and antibodies to treat bacterial infections.

Current Investors

Alderley Park Ventures, SPARK Ventures, North West Business Finance

Request a demo

Primary Industry

Pharmaceuticals

Sub Industries

Epidemiology, Pharmaceutical Research & Development

Website

www.absynthbiologics.co.uk

Verticals

Manufacturing

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Absynth Biologics Ltd. - financials

Fiscal Year Ended	Jul 31, 2010	Jul 31, 2011	Jul 31, 2012	Jul 31, 2013	Jul 31, 2014	Jul 31, 2015	Jul 31, 2016
Revenue (USD)	-	204,500	256,567	43,133	-	-	-
% Revenue Growth (YoY)	-	-	25.5%	(83.2%)	-	-	-
EBITDA (USD)	(62,920)	129,654	(241,746)	(331,377)	-	-	-
Operating Income (USD)	(65,238)	127,336	(244,064)	(333,695)	-	-	-
Operating Margin	-	62.3%	(95.1%)	(773.6%)	-	-	-
% EBITDA Margin	-	63.4%	(94.2%)	(768.3%)	-	-	-
NET Income (USD)	(75,883)	115,225	(256,670)	(324,238)	-	-	-
% Net Margin	-	56.3%	(100.0%)	(751.7%)	-	-	-

Absynth Biologics Ltd. - employee data

Want to see Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Request demo